Q2 2025 13F Holders as of 30 Jun 2025
-
Type / Class
-
Equity / COM
-
Number of holders
-
51
-
Total 13F shares, excl. options
-
1.23M
-
Shares change
-
+157K
-
Total reported value, excl. options
-
$11.2M
-
Value change
-
+$1.42M
-
Number of buys
-
27
-
Number of sells
-
-13
-
Price
-
$9.07
Significant Holders of Greenwich LifeSciences, Inc. - COM (GLSI) as of Q2 2025
54 filings reported holding GLSI - Greenwich LifeSciences, Inc. - COM as of Q2 2025.
Greenwich LifeSciences, Inc. - COM (GLSI) has 51 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 1.23M shares
.
Largest 10 shareholders include BlackRock, Inc. (367K shares), VANGUARD GROUP INC (269K shares), GEODE CAPITAL MANAGEMENT, LLC (139K shares), NORTHERN TRUST CORP (82.8K shares), STATE STREET CORP (82.2K shares), MARSHALL WACE, LLP (56.1K shares), MILLENNIUM MANAGEMENT LLC (34.2K shares), RENAISSANCE TECHNOLOGIES LLC (27.3K shares), STRS OHIO (20K shares), and CHARLES SCHWAB INVESTMENT MANAGEMENT INC (19K shares).
This table shows the top 51 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.